{"id":"https://openalex.org/W4405048856","doi":"https://doi.org/10.1182/blood-2024-198392","title":"Impact of CD34+ Graft Cell Dose on Outcomes after Allogeneic Peripheral Blood Stem Cell Transplantation","display_name":"Impact of CD34+ Graft Cell Dose on Outcomes after Allogeneic Peripheral Blood Stem Cell Transplantation","alternate_titles":[],"publication_year":2024,"publication_date":"2024-11-05","ids":{"openalex":"https://openalex.org/W4405048856","doi":"https://doi.org/10.1182/blood-2024-198392"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2024-198392","doi":"https://doi.org/10.1182/blood-2024-198392","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood-2024-198392","pdf_url":"https://ashpublications.org/blood/article-pdf/144/Supplement 1/7305/2324736/blood-10130-main.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4405048856"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ashpublications.org/blood/article-pdf/144/Supplement 1/7305/2324736/blood-10130-main.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089584574","display_name":"Sibgha Gull Chaudhary","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128618","display_name":"University of Kansas Medical Center","ror":"https://ror.org/036c9yv20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210128618"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sibgha Gull Chaudhary","raw_affiliation_strings":["1Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS","2US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS","3Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS","institution_ids":[]},{"raw_affiliation_string":"2US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS","institution_ids":[]},{"raw_affiliation_string":"3Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS","institution_ids":["https://openalex.org/I4210128618"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091688355","display_name":"Moazzam Shahzad","orcid":"https://orcid.org/0000-0002-9609-6160","observed_orcids":["https://orcid.org/0000-0002-9609-6160"]},"institutions":[{"id":"https://openalex.org/I2613432","display_name":"University of South Florida","ror":"https://ror.org/032db5x82","country_code":"US","type":"education","lineage":["https://openalex.org/I2613432"]},{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Moazzam Shahzad","raw_affiliation_strings":["1Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS","4Department of Oncological Sciences, H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS","institution_ids":[]},{"raw_affiliation_string":"4Department of Oncological Sciences, H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL","institution_ids":["https://openalex.org/I2613432","https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108298463","display_name":"Iqra Anwar","orcid":"https://orcid.org/0009-0004-3046-8875","observed_orcids":["https://orcid.org/0009-0004-3046-8875"]},"institutions":[{"id":"https://openalex.org/I4210128618","display_name":"University of Kansas Medical Center","ror":"https://ror.org/036c9yv20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210128618"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Iqra Anwar","raw_affiliation_strings":["1Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS","2US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS","3Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS","institution_ids":[]},{"raw_affiliation_string":"2US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS","institution_ids":[]},{"raw_affiliation_string":"3Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS","institution_ids":["https://openalex.org/I4210128618"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021454848","display_name":"Muhammad Kashif Amin","orcid":"https://orcid.org/0000-0002-4052-7339","observed_orcids":["https://orcid.org/0000-0002-4052-7339"]},"institutions":[{"id":"https://openalex.org/I4210128618","display_name":"University of Kansas Medical Center","ror":"https://ror.org/036c9yv20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210128618"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Muhammad Kashif Amin","raw_affiliation_strings":["1Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS","2US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS","3Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS","institution_ids":[]},{"raw_affiliation_string":"2US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS","institution_ids":[]},{"raw_affiliation_string":"3Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS","institution_ids":["https://openalex.org/I4210128618"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109769248","display_name":"Sohaib Irfan","orcid":"https://orcid.org/0009-0008-3133-5993","observed_orcids":["https://orcid.org/0009-0008-3133-5993"]},"institutions":[{"id":"https://openalex.org/I4210128618","display_name":"University of Kansas Medical Center","ror":"https://ror.org/036c9yv20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210128618"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sohaib Irfan","raw_affiliation_strings":["1Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS","5Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS","institution_ids":[]},{"raw_affiliation_string":"5Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS","institution_ids":["https://openalex.org/I4210128618"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061884214","display_name":"Matthew McGuirk","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128618","display_name":"University of Kansas Medical Center","ror":"https://ror.org/036c9yv20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210128618"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew McGuirk","raw_affiliation_strings":["1Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS","2US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS","3Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS","institution_ids":[]},{"raw_affiliation_string":"2US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS","institution_ids":[]},{"raw_affiliation_string":"3Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS","institution_ids":["https://openalex.org/I4210128618"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104206516","display_name":"Shaun DeJarnette","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128618","display_name":"University of Kansas Medical Center","ror":"https://ror.org/036c9yv20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210128618"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shaun DeJarnette","raw_affiliation_strings":["6University of Kansas Medical Center, Kansas City, KS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6University of Kansas Medical Center, Kansas City, KS","institution_ids":["https://openalex.org/I4210128618"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088949367","display_name":"Nausheen Ahmed","orcid":"https://orcid.org/0000-0003-4336-4982","observed_orcids":["https://orcid.org/0000-0003-4336-4982"]},"institutions":[{"id":"https://openalex.org/I4210128618","display_name":"University of Kansas Medical Center","ror":"https://ror.org/036c9yv20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210128618"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nausheen Ahmed","raw_affiliation_strings":["1Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS","2US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS","5Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS","institution_ids":[]},{"raw_affiliation_string":"2US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS","institution_ids":[]},{"raw_affiliation_string":"5Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS","institution_ids":["https://openalex.org/I4210128618"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030746256","display_name":"Al-Ola A. Abdallah","orcid":"https://orcid.org/0000-0002-6603-185X","observed_orcids":["https://orcid.org/0000-0002-6603-185X"]},"institutions":[{"id":"https://openalex.org/I4210128618","display_name":"University of Kansas Medical Center","ror":"https://ror.org/036c9yv20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210128618"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Al-Ola Abdallah","raw_affiliation_strings":["1Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS","2US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS","5Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS","institution_ids":[]},{"raw_affiliation_string":"2US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS","institution_ids":[]},{"raw_affiliation_string":"5Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS","institution_ids":["https://openalex.org/I4210128618"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086587597","display_name":"Sunil Abhyankar","orcid":"https://orcid.org/0000-0002-8578-1226","observed_orcids":["https://orcid.org/0000-0002-8578-1226"]},"institutions":[{"id":"https://openalex.org/I4210128618","display_name":"University of Kansas Medical Center","ror":"https://ror.org/036c9yv20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210128618"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sunil Abhyankar","raw_affiliation_strings":["1Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS","2US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS","3Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS","institution_ids":[]},{"raw_affiliation_string":"2US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS","institution_ids":[]},{"raw_affiliation_string":"3Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS","institution_ids":["https://openalex.org/I4210128618"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052064208","display_name":"Joseph P. McGuirk","orcid":"https://orcid.org/0000-0002-0539-4796","observed_orcids":["https://orcid.org/0000-0002-0539-4796"]},"institutions":[{"id":"https://openalex.org/I4210128618","display_name":"University of Kansas Medical Center","ror":"https://ror.org/036c9yv20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210128618"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph P. McGuirk","raw_affiliation_strings":["1Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS","2US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS","5Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS","institution_ids":[]},{"raw_affiliation_string":"2US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS","institution_ids":[]},{"raw_affiliation_string":"5Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS","institution_ids":["https://openalex.org/I4210128618"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5041882264","display_name":"Muhammad Umair Mushtaq","orcid":"https://orcid.org/0000-0001-8122-0563","observed_orcids":["https://orcid.org/0000-0001-8122-0563"]},"institutions":[{"id":"https://openalex.org/I4210128618","display_name":"University of Kansas Medical Center","ror":"https://ror.org/036c9yv20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210128618"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Muhammad Umair Mushtaq","raw_affiliation_strings":["1Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS","2US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS","5Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS","institution_ids":[]},{"raw_affiliation_string":"2US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS","institution_ids":[]},{"raw_affiliation_string":"5Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS","institution_ids":["https://openalex.org/I4210128618"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"144","issue":"Supplement 1","first_page":"7305","last_page":"7305"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11189","display_name":"Transplantation: Methods and Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10373","display_name":"Renal Transplantation Outcomes and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/allogeneic-peripheral-blood-stem-cell-transplantation","display_name":"allogeneic peripheral blood stem cell transplantation","score":0.9829999804496765},{"id":"https://openalex.org/keywords/matched-unrelated-donor","display_name":"matched unrelated donor","score":0.746999979019165},{"id":"https://openalex.org/keywords/haploidentical-transplantation","display_name":"haploidentical transplantation","score":0.9279999732971191},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6610000133514404},{"id":"https://openalex.org/keywords/disease-free-survival","display_name":"disease-free survival","score":0.9089999794960022},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.7260000109672546},{"id":"https://openalex.org/keywords/treatment-related-mortality","display_name":"non-relapse mortality","score":0.9819999933242798},{"id":"https://openalex.org/keywords/graft-versus-host-disease","display_name":"graft-versus-host disease","score":0.9539999961853027},{"id":"https://openalex.org/keywords/engraftment","display_name":"engraftment","score":0.7760000228881836},{"id":"https://openalex.org/keywords/conditioning-regimen","display_name":"conditioning regimen","score":0.5809999704360962},{"id":"https://openalex.org/keywords/myeloablative-conditioning","display_name":"myeloablative conditioning","score":0.7720000147819519},{"id":"https://openalex.org/keywords/reduced-intensity-conditioning","display_name":"reduced-intensity conditioning","score":0.9940000176429749},{"id":"https://openalex.org/keywords/hematopoietic-stem-cell-transplantation","display_name":"hematopoietic stem cell transplantation","score":0.5609999895095825}],"concepts":[{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.7063049674034119},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.6637519598007202},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5647896528244019},{"id":"https://openalex.org/C3017910909","wikidata":"https://www.wikidata.org/wiki/Q618363","display_name":"Peripheral blood","level":2,"score":0.5290205478668213},{"id":"https://openalex.org/C2909265885","wikidata":"https://www.wikidata.org/wiki/Q2329938","display_name":"Peripheral Blood Stem Cells","level":4,"score":0.5235347747802734},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.4136374592781067},{"id":"https://openalex.org/C46762472","wikidata":"https://www.wikidata.org/wiki/Q178648","display_name":"Peripheral","level":2,"score":0.4123295545578003},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4111538231372833},{"id":"https://openalex.org/C2777408962","wikidata":"https://www.wikidata.org/wiki/Q1128050","display_name":"Hematopoietic stem cell transplantation","level":3,"score":0.3426937758922577},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.30437594652175903},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2536756992340088},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2024-198392","doi":"https://doi.org/10.1182/blood-2024-198392","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood-2024-198392","pdf_url":"https://ashpublications.org/blood/article-pdf/144/Supplement 1/7305/2324736/blood-10130-main.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1182/blood-2024-198392","doi":"https://doi.org/10.1182/blood-2024-198392","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood-2024-198392","pdf_url":"https://ashpublications.org/blood/article-pdf/144/Supplement 1/7305/2324736/blood-10130-main.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4405048856.pdf","grobid_xml":"https://content.openalex.org/works/W4405048856.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2397947478","https://openalex.org/W4405046146","https://openalex.org/W4405048629","https://openalex.org/W4311495735","https://openalex.org/W3003100219","https://openalex.org/W3213035984","https://openalex.org/W4390452409","https://openalex.org/W4413037672","https://openalex.org/W4405048942","https://openalex.org/W2944535240"],"abstract_inverted_index":{"Background:":[0],"CD34+":[1,226,242,257,276,423,464],"graft":[2,25,46,120,166,219,232,247,327,361,390,407,424,442,454],"cell":[3,14,26,47,167,220,233,248,260,328,362,391,408,425,439,443,455],"dose":[4,27,48,221,234,249,261,329,363,392,409,426,444,456],"is":[5,35],"imperative":[6],"to":[7,41,83,111,142,161,341,352],"outcomes":[8,29,50],"after":[9,30,434,457],"allogeneic":[10,435],"peripheral":[11,436],"blood":[12,437],"stem":[13,438],"transplantation":[15],"(allo-PBSCT).":[16],"A":[17,388,405],"few":[18],"studies":[19],"have":[20],"evaluated":[21],"the":[22,33,43,74,149,163,245,321],"effect":[23],"of":[24,45,76,165,213,360,475],"on":[28,49],"allo-PBSCT;":[31],"however,":[32,441],"data":[34,179],"limited":[36],"and":[37,68,93,118,125,145,148,156,172,210,244,271,279,287,297,311,344,370,373,386,431],"heterogeneous.":[38],"We":[39,188],"aimed":[40],"investigate":[42],"impact":[44,164,402,448],"following":[51],"allo-PBSCT.":[52],"Methods:":[53],"In":[54],"this":[55],"retrospective":[56],"single-center":[57],"study,":[58],"we":[59],"included":[60,189,293,304],"all":[61],"patients":[62,214],"undergoing":[63],"matched":[64],"unrelated":[65],"donor":[66,383],"(MUD)":[67],"haploidentical":[69],"(haplo)":[70],"allo-PBSCT":[71,191,458],"(n=224)":[72],"at":[73,185],"University":[75],"Kanas":[77],"Medical":[78],"Center":[79],"from":[80],"August":[81],"2016":[82],"July":[84],"2021.":[85],"Cox":[86],"regression":[87,108,139,323],"analysis":[88,381],"compared":[89],"overall":[90],"survival":[91,95,128],"(OS)":[92],"disease-free":[94],"(DFS).":[96],"Hazard":[97],"ratios":[98,131],"(HR)":[99],"with":[100,133,333,364,418],"95%":[101,134,338,349],"confidence":[102],"intervals":[103],"(CI)":[104],"were":[105,136,159,176,215,282,377],"calculated.":[106,137,154],"Logistic":[107],"was":[109,140,153,183,206,222,239,254,262,330,356,416],"performed":[110,141,160,283],"compare":[112,143],"relapse,":[113],"non-relapse":[114],"mortality":[115],"(NRM),":[116],"acute":[117,369],"chronic":[119,371],"versus":[121],"host":[122],"disease":[123],"(GVHD),":[124],"GVHD-free":[126],"Relapse-free":[127],"(GRFS).":[129],"Odds":[130],"(0R)":[132],"CI":[135,339,350],"Linear":[138],"platelet":[144,346,432],"neutrophil":[146,335,430],"engraftment,":[147],"correlation":[150],"coefficient":[151],"(R)":[152],"Univariate":[155],"multivariate":[157,322],"analyses":[158],"explore":[162],"dose.":[168],"SPSS":[169],"version":[170,174],"28":[171],"R":[173],"4.16":[175],"used":[177],"for":[178,317],"analysis.":[180],"Statistical":[181],"significance":[182],"considered":[184],"p<0.05.":[186],"Results:":[187],"224":[190],"recipients":[192,238,253],"who":[193],"received":[194],"a":[195,325,472],"MUD":[196,236],"(n=110)":[197],"or":[198],"Haplo":[199],"(n=114)":[200],"PBSCT.":[201],"The":[202,217,230,452],"median":[203,218,231,246],"recipient":[204],"age":[205],"56.75":[207],"(19.23-74.40)":[208],"years,":[209],"63%":[211],"(n=141)":[212],"male.":[216],"5.63":[223],"(0.98-16.6)":[224],"million":[225,241,256,273,394,411,463],"cells":[227,396,413],"per":[228,397,414],"kg.":[229],"in":[235,250,284,320,379,428,471],"PBSCT":[237,252],"7.22":[240],"cells/kg,":[243],"haplo":[251],"5.03":[255],"cells/kg.":[258,277,465],"Graft":[259],"categorized":[263],"as":[264],"<5":[265],"(29%,":[266],"n=64),":[267],"5-8":[268],"(48%,":[269],"n=108),":[270],">8":[272],"(23%,":[274],"n=52)":[275],"Myeloablative":[278],"reduced-intensity":[280],"conditioning":[281],"88":[285],"(39%)":[286],"136":[288],"(61%)":[289],"recipients.":[290],"GVHD":[291],"prophylaxis":[292],"tacrolimus/methotrexate":[294],"(n=98,":[295],"44%)":[296],"post-transplant":[298,403,450],"cyclophosphamide-based":[299],"(n=126,":[300],"56%).":[301],"Hematologic":[302],"diagnoses":[303],"myeloid":[305],"(n=157,":[306],"70%),":[307],"lymphoid":[308],"(n=54,":[309],"24%),":[310],"others":[312],"(n=13,":[313],"6%).":[314],"After":[315],"adjusting":[316],"significant":[318,358],"variables":[319],"models,":[324],"higher":[326,389],"significantly":[331,447],"associated":[332,417],"faster":[334,345,429],"engraftment":[336,347,433],"(R=-0.256,":[337],"-0.448":[340],"-0.064,":[342],"p=0.0091)":[343],"(R=-1.054,":[348],"-1.945":[351],"-0.163,":[353],"p=0.02).":[354],"There":[355],"no":[357],"association":[359],"OS,":[365],"DFS,":[366],"Relapse,":[367],"NRM,":[368],"GVHD,":[372],"GRFS.":[374],"Similar":[375],"trends":[376],"seen":[378],"sub-group":[380],"by":[382],"type":[384],"(MUD":[385],"haplo).":[387],"(>8":[393],"CD34":[395,412],"kg)":[398,415],"did":[399],"not":[400,446],"adversely":[401],"outcomes.":[404,451],"lower":[406],"(<5":[410],"slower":[419],"engraftment.":[420],"Conclusion:":[421],"Higher":[422],"results":[427],"transplantation;":[440],"does":[445],"other":[449],"optimal":[453],"might":[459],"be":[460,469],"over":[461],"5":[462],"Our":[466],"findings":[467],"should":[468],"validated":[470],"larger":[473],"cohort":[474],"patients.":[476]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4405048856","counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2024-12-06T00:00:00"}
